Yes, CABG Can Be Performed Using Multiple Vessels Beyond the Saphenous Vein
Multiple arterial conduits are not only available but are actually preferred over saphenous vein grafts for CABG, with the radial artery and internal mammary arteries offering superior long-term outcomes. 1
Primary Conduit Options
Internal Mammary Arteries (IMA)
- The left internal mammary artery (LIMA) to the LAD is the gold standard and should be used whenever technically feasible, as it improves survival and reduces recurrent ischemic events 1
- The right internal mammary artery (RIMA) is biologically equivalent to the LIMA and can be used for additional grafts
- Bilateral IMA (BIMA) grafting by experienced operators provides a survival advantage over single IMA use, though it requires greater technical expertise 1
- Harvest using skeletonization technique to reduce sternal wound complications 1
Radial Artery
- The radial artery is recommended over saphenous vein for the second most important non-LAD target vessel (Class I recommendation) 1
- Demonstrates better mid- and long-term patency rates than saphenous vein 1
- Pooled analysis of 6 randomized trials showed improved cardiac outcomes at 5 and 10 years compared to saphenous vein 1
- Patients <75 years, women, and those with preserved renal function benefit most 1
Right Gastroepiploic Artery
- Can be used by experienced operators to graft right coronary artery targets with subocclusive stenosis 1
- Requires skeletonization technique
- Less commonly used but viable option
Critical Pre-Harvest Assessments
For radial artery use:
- Objectively assess palmar arch completeness and ulnar compensation before harvesting 1
- Use the arm with best ulnar compensation
- Avoid after transradial catheterization
- Avoid in patients with chronic kidney disease likely to progress to hemodialysis
- Target vessels with subocclusive stenoses
- Prescribe oral calcium channel blockers for first postoperative year to prevent spasm 1
Evidence for Total Arterial Revascularization
Avoiding saphenous vein grafts entirely (total arterial revascularization) shows significant mortality benefit. A literature review of 127,565 matched patients found reduced all-cause mortality (HR: 0.78; 95% CI: 0.72-0.85; P < 0.001) at mean 8.8 years postoperatively 2. This reflects the reality that saphenous vein grafts develop progressive atherosclerosis with 50% occlusion by 10 years, while arterial conduits show minimal progressive failure 2.
Common Pitfalls to Avoid
- Do not use bilateral radial arteries - preserve one for future procedures 1
- Do not harvest radial artery without confirming ulnar compensation - risk of hand ischemia
- Do not use radial artery for targets without significant stenosis - competitive flow increases graft failure 1
- Do not assume saphenous vein is equivalent to arterial conduits - the evidence clearly favors arterial grafts for long-term outcomes 1, 2
Practical Algorithm for Conduit Selection
- LIMA to LAD (mandatory unless contraindicated)
- Radial artery for second most important non-LAD vessel (if ulnar compensation adequate and no CKD)
- RIMA or additional radial artery for remaining targets (if experienced operator)
- Right gastroepiploic artery for RCA targets (if experienced operator)
- Saphenous vein only when arterial conduits exhausted or contraindicated
The extensive use of arterial conduits (>2) instead of saphenous vein grafts may provide additional late mortality benefit compared to CABG with only 2 arterial grafts 1.